These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26999939)

  • 21. Subretinal versus intravitreal injection of recombinant tissue plasminogen activator in post-traumatic submacular haemorrhages.
    Buschini E; Iannetta D; Lesnik Oberstein SY; Bijl HM; Mura M
    Acta Ophthalmol; 2016 May; 94(3):307-9. PubMed ID: 26283643
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TISSUE PLASMINOGEN ACTIVATOR FOR SUBFOVEAL HEMORRHAGE DUE TO AGE-RELATED MACULAR DEGENERATION: Comparison of 3 Treatment Modalities.
    Fassbender JM; Sherman MP; Barr CC; Schaal S
    Retina; 2016 Oct; 36(10):1860-5. PubMed ID: 26945238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S; Mahieu L; Lequeux L; Quintyn JC; Pagot-Mathis V
    J Fr Ophtalmol; 2010 Feb; 33(2):84-91. PubMed ID: 20092910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of macular hematoma complicating AMD by vitrectomy, subretinal r-TPA injection, intravitreal injection of bevacizumab combined with gas tamponade: Report of 4 cases].
    Abboud M; Benzerroug M; Milazzo S
    J Fr Ophtalmol; 2017 Feb; 40(2):133-137. PubMed ID: 28189348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of submacular hemorrhage with low-dose intravitreal tissue plasminogen activator injection and pneumatic displacement.
    Handwerger BA; Blodi BA; Chandra SR; Olsen TW; Stevens TS
    Arch Ophthalmol; 2001 Jan; 119(1):28-32. PubMed ID: 11146723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH; van Zeeburg EJ; Cereda MG; van Velthoven ME; Faridpooya K; Vermeer KA; van Meurs JC
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-patient management and treatment satisfaction after intravitreous plasminogen activator injection.
    Mozaffarieh M; Heinzl H; Sacu S; Wedrich A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1421-8. PubMed ID: 16596407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and structural outcome after vitrectomy combined with subretinal rtPA Injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages.
    Rickmann A; Paez LR; Della Volpe Waizel M; Bisorca-Gassendorf L; Schulz A; Vandebroek AC; Szurman P; Januschowski K
    PLoS One; 2021; 16(4):e0250587. PubMed ID: 33930041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
    Guthoff R; Guthoff T; Meigen T; Goebel W
    Retina; 2011 Jan; 31(1):36-40. PubMed ID: 20921929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combination of Intravitreal rTPA, gas and ranibizumab for extensive subfoveal haemorrhages secondary to neovascular age-related macular degeneration].
    Matt G; Sacu S; Stifter E; Prünte C; Schmidt-Erfurth U
    Klin Monbl Augenheilkd; 2010 Mar; 227(3):221-5. PubMed ID: 20234987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitrectomy for the treatment of submacular hemorrhages from macular degeneration: a comparison of submacular hemorrhage/membrane removal and submacular tissue plasminogen activator-assisted pneumatic displacement.
    Thompson JT; Sjaarda RN
    Trans Am Ophthalmol Soc; 2005; 103():98-107; discussion 107. PubMed ID: 17057793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal injection of recombinant tissue plasminogen activator in submacular hemorrhage: case series.
    Araújo J; Sousa C; Faria PA; Carneiro Â; Rocha-Sousa A; Falcão-Reis F
    Eur J Ophthalmol; 2016 Apr; 26(3):e49-51. PubMed ID: 26428222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
    Krepler K; Kruger A; Tittl M; Stur M; Wedrich A
    Retina; 2000; 20(3):251-6. PubMed ID: 10872929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling procedures.
    Chen SN; Ho CL; Kuo YH; Ho JD
    Retina; 2001; 21(5):460-3. PubMed ID: 11642374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ; Ho-Yen G; Clarke B; Barbara R; Lash S; Papathomas T; Antonakis S; Gupta B
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical results of intravitreal administration of tissue-type plasminogen activator (tPA) and gas for removal of subretinal hemorrhage in senile macular degeneration].
    Framme C; Toukhy HE; Sachs HG; Spiegel D; Roider J; Gabel VP; Lohmann CP
    Klin Monbl Augenheilkd; 2000 Jan; 216(1):33-9. PubMed ID: 10702940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration.
    Sacu S; Stifter E; Vécsei-Marlovits PV; Michels S; Schütze C; Prünte C; Schmidt-Erfurth U
    Eye (Lond); 2009 Jun; 23(6):1404-10. PubMed ID: 18756282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal Versus Subretinal Tissue Plasminogen Activator Injection for Submacular Hemorrhage.
    Bell JE; Shulman JP; Swan RJ; Teske MP; Bernstein PS
    Ophthalmic Surg Lasers Imaging Retina; 2017 Jan; 48(1):26-32. PubMed ID: 28060391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.